Abgenom is committed to developing, commercializing and popularizing advanced In Vitro Diagnostic (IVD) kits/devices to improve health of human being. Its primarily business is to design, develop, patent and market home-applicable diagnostic test kits and portable diagnostic devices related to cardiovascular diseases and infectious diseases, specifically for the early detection of acute myocardial infarction (AMI) and infectious diseases, especially for the detection of AIDS, hepatitis, and STDs (Sexual Transmitted Diseases).

The company's principal objective is to become a leading supplier in both US and China's molecular diagnosis and home-applicable end-user IVD market in 4-5 years. In the long run, we want to be the leader in the development and production of high quality, cutting-edge diagnostic products for various human diseases.

Abgenom also makes a difference in the development of novel rapid, simple, cost effective and high performance diagnostic tests for use in resource-limited settings in both the developing and developed world. These tests will be particularly applicable to clinical settings in which a rapid and immediate test result is crucial.